Tissue pressure test to guide fluid treatment in shock
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study tests whether measuring the pressure in your tissues can help doctors decide if you need more fluids while in the intensive care unit (ICU) for shock. It aims to improve how fluids are given to patients with shock.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the intensive care unit (ICU).
- You have been diagnosed with shock and your body shows signs of not getting enough blood flow.
- Your doctor has decided you need fluids to help your blood pressure and circulation.
- You are already having your blood pressure monitored with a small tube in an artery (invasive monitoring).
- You are not pregnant.
- You are not expected to need a machine to support your heart or lungs (like ECMO) right away.
- Your doctor expects you to live for at least 3 more days.
- You are able to give written permission to be in the study, or someone can do it for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies different ways to measure how much extra fluid your body can handle when you are in shock. The goal is to see which method works best and helps doctors make better decisions about fluid treatment.
This study is testing whether a simple ultrasound technique can help doctors decide if you need more fluids when you have shock. The goal is to improve fluid management in intensive care patients.
This study checks whether a specific heart ultrasound measurement can help doctors decide if you will benefit from extra fluid during early emergency treatment for shock. It may help avoid unnecessary fluids and support faster, safer decision-making.
This study compares individualized blood pressure goals versus the usual (standard) targets for adults in the ICU with shock. The aim is to see whether tailored blood pressure treatment can improve outcomes by better matching each person’s needs.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This study watches how the right side of your heart responds when doctors give you extra fluids to improve blood flow during a critical illness. Understanding this response may help doctors make better decisions about fluid treatment in the ICU.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.